Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC

Conditions: Arrhythmogenic Right Ventricular Cardiomyopathy Interventions: Genetic: TN-401 Sponsors: Tenaya Therapeutics Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials